All terms in EFO
| Label | Id | Description |
|---|---|---|
| Severe failure to thrive | HP_0001525 | |
| anti-centromere-antibody-positive systemic scleroderma | EFO_0008536 | [A sub-type of systemic scleroderma characterised by the presence of antibodies to centromere proteins] |
| anti-topoisomerase-I-antibody-positive systemic scleroderma | EFO_0008537 | [A sub-type of systemic scleroderma characterised by the presence of antibodies to topoisomerase-1 protein] |
| helping behavior measurement | EFO_0008538 | [Quantification of some aspect of helping behavior, for example helping others without being paid. Helping behavior is an example of prosocial behavior.] |
| helping behaviour | EFO_0008540 | [Some aspect of helping behavior, for example helping others without being paid. Helping behavior is an example of prosocial behavior.] |
| vitamin D dietary intake measurement | EFO_0008539 | [Quantification of dietary vitamin D intake.] |
| Vitamin D | CHEBI_27300 | [Vitamin D is a group of fat-soluble prohormones, which can be obtained from sun exposure, food and supplements. Vitamin D is biologically inactive and converted to the biologically active calcicitriol via double hydroxilation in the body.] |
| glycochenodeoxycholate 7-sulfate(2-) | CHEBI_58877 | [A steroid sulfate oxoanion obtained by deprotonation of the carboxylic acid and sulfate functions of glycochenodeoxycholic acid 7-sulfate.] |
| hyodeoxycholate | CHEBI_58875 | [A bile acid anion that is the conjugate base of hyodeoxycholic acid.] |
| obsolete_partial duplication of the long arm of chromosome 19 | Orphanet_262986 | |
| Leprechaunism | Orphanet_508 | [Leprechaunism is a congenital form of extreme insulin resistance (a group of syndromes that also includes Rabson-Mensenhall syndrome, type A insulin-resistance syndrome, and acquired type B insulin-resistance syndrome; see these terms) characterized by intrauterine and mainly postnatal severe growth retardation.] |
| obsolete_Leigh syndrome | Orphanet_506 | |
| obsolete_Graham Little-Piccardi-Lassueur syndrome | Orphanet_505 | [Graham Little-Piccardi-Lassueur syndrome is a variant of lichen planopilaris (see this term) characterized by the clinical triad of progressive cicatricial (scarring) alopecia of the scalp, follicular keratotic papules on glabrous skin, and variable alopecia of the axillae and groin.] |
| Autosomal dominant Larsen syndrome | Orphanet_503 | [Larsen syndrome (LS) is a rare skeletal dysplasia characterized by congenital dislocation of large joints, foot deformities, cervical spine dysplasia, scoliosis, spatula-shaped distal phalanges and distinctive craniofacial abnormalities, including cleft palate.] |
| secondary progressive multiple sclerosis | EFO_0008522 | [Secondary progressive multiple sclerosis is the form of the multiple sclerosis in which an initial relapsing-remitting phase is followed by a progressive phase – defined as an accumulation of disability regardless of relapses, with or without persistence of superimposed relapses., A multiple sclerosis with a clinical course characterized by a progressive accumulation of neurological disability, independent of relapses, following an initial relapsing-remitting (RR) phase.] |
| Langer-Giedion syndrome | Orphanet_502 | |
| sessile serrated polyp | EFO_0008523 | [A sessile serrated polyp is a serrated polyp that demonstrates abnormal cellular proliferation characterized by a proximally displaced proliferative zone, epithelial serrations, and characteristic distorted basilar crypt architecture with crypt dilation, branching, and lateral growth along the muscularis mucosa.] |
| obsolete_Lafora disease | Orphanet_501 | |
| obsolete_LEOPARD syndrome | Orphanet_500 | |
| primary progressive multiple sclerosis | EFO_0008520 | [A multiple sclerosis that is characterized by steady worsening of neurologic functioning, without any distinct relapses or periods of remission. The rate of progression may vary over time, with occasional plateaus or temporary improvements, but the progression is continuous., Primary progressive multiple sclerosis is the form of the multiple sclerosis in which clinical disability progression occurs continuously without remissions.] |